Mitogen-activated protein kinase mediation of hemolysate-induced contraction in rabbit basilar artery

Journal of Neurosurgery

Volumn 90, Issue 6, 1999, Pages 1091-1097

  Zubkov, Alexander Y ^a   Ogihara, Kotaro ^a   Tumu, Phani ^a   Patlolla, Anita ^a   Lewis, Adam I ^a   Parent, Andrew D ^a   Zhang, John ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Cerebral vasospasm; Hemolysate; Mitogen activated protein kinase; Rabbit; Rabbit basilar artery

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; PROTEIN TYROSINE KINASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; BASILAR ARTERY; BRAIN VASOSPASM; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; HEMOLYSATE; IMMUNOBLOTTING; MALE; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 0032970813     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.1999.90.6.1091     Document Type: Article

References (48)

1. Adam LP, Franklin MT, Raff GJ, et al: Activation of mitogen-activated protein kinase in porcine carotid arteries. Circ Res 76:183-190, 1995
2. Adam LP, Hathaway DR: Identification of mitogen-activated protein kinase phosphorylation sequences in mammalian h-Caldesmon. FEBS Lett 322:56-60, 1993
3. Alessi DR, Cuenda A, Cohen P, et al: PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 270:27489-27494, 1995
4. Berk BC, Corson MA: Angiotensin II signal transduction in vascular smooth muscle. Role of tyrosine kinases. Circ Res 80:607-616, 1997
5. Childs TJ, Mak AS: MAP kinases from bovine brain: purification and characterization. Biochem Cell Biol 71:544-555, 1993
6. Childs TJ, Mak AS: Smooth-muscle mitogen-activated protein (MAP) kinase: purification and characterization, and the phosphorylation of caldesmon. Biochem J 296:745-751, 1993
7. Earley JJ, Su X, Moreland RS: Caldesmon inhibits active cross-bridges in unstimulated vascular smooth muscle. An antisense oligodeoxynucleotide approach. Circ Res 83:661-667, 1998
8. Epstein AM, Throckmorton D, Brophy CM: Mitogen-activated protein kinase activation: an alternate signaling pathway for sustained vascular smooth muscle contraction. J Vasc Surg 26: 327-332, 1997
9. lck. Science 255: 853-855, 1992
10. lck tyrosine kinase activity. Biochemistry 34:12404-12410, 1995
11. Force T, Bonventre JV: Growth factors and mitogen-activated protein kinases. Hypertension 31:152-161, 1998
12. Fukami M, Tani E, Takai A, et al: Activity of smooth muscle phosphatases 1 and 2A in rabbit basilar artery in vasospasm. Stroke 26:2321-2327, 1995
13. Glenney JR Jr: Tyrosine-phosphorylated proteins: mediators of signal transduction from the tyrosine kinases. Biochim Biophys Acta 1134:113-127, 1992
14. Griendling KK, Ushio-Fukai M, Lassègue B, et al: Angiotensin II signaling in vascular smooth muscle. New concepts. Hypertension 29:366-373, 1997
15. Hardy K, Chaudhri G: Activation and signal transduction via mitogen-activated protein (MAP) kinases in T lymphocytes. Immunol Cell Biol 75:528-545, 1997
16. i-coupled receptors. Biochem Biophys Res Commun 244:5-10, 1998
17. Ishida M, Ishida T, Thomas SM, et al: Activation of extracellular signal-regulated kinases (ERK 1/2) by angiotensin II is dependent on c-Src in vascular smooth muscle cells. Circ Res 82: 7-12, 1998
18. c-src in vascular smooth muscle cells. Circ Res 77: 1053-1059, 1995
19. Kassell NF, Helm G, Simmons N, et al: Treatment of cerebral vasospasm with intra-arterial papaverine. J Neurosurg 77: 848-852, 1992
20. Katoch SS, Moreland RS: Agonist and membrane depolarization induced activation of MAP kinase in the swine carotid artery. Am J Physiol 269:H222-H229, 1995
21. Khalil RA, Morgan KG: PKC-mediated redistribution of mitogen-activated protein kinase during smooth muscle cell activation. Am J Physiol 265:C406-C411, 1993
22. Kim CJ, Kim KW, Park JW, et al: Role of tyrosine kinase in erythrocyte lysate-induced contraction in rabbit cerebral arteries. J Neurosurg 89:289-296, 1998
23. Kribben A, Wieder ED, Li X, et al: AVP-induced activation of MAP kinase in vascular smooth muscle cells is mediated through protein kinase C. Am J Physiol 265:C939-C945, 1993
24. Macdonald RL, Wang X, Zhang J, et al: Molecular changes with subarachnoid hemorrhage and vasospasm, in Raffel C, Harsh GR IV (eds): The Molecular Basis of Neurosurgical Disease. Baltimore: Williams & Wilkins, 1996, pp 278-293
25. Macdonald RL, Weir BK: Cerebral vasospasm and free radicals. Free Rad Biol Med 16:633-643, 1994
26. i elevation induced by hemolysate in bovine endothelial cells: implications for cerebral vasospasm. Neurol Res 18: 349-353, 1996
27. Matsui T, Asano T: Protein kinase C and vasospasm. J Neurosurg 85:1197-1198, 1996 (Letter)
28. Matsui T, Takuwa Y, Johshita H, et al: Possible role of protein kinase C-dependent smooth muscle contraction in the pathogenesis of chronic cerebral vasospasm. J Cereb Blood Flow Metab 11:143-149, 1991
29. Mayberg MR, Okada T, Bark DH: Morphologic changes in cerebral arteries after subarachnoid hemorrhage. Neurosurg Clin North Am 1:417-432, 1990
30. Minami N, Tani E, Maeda Y, et al: Effects of inhibitors of protein kinase C and calpain in experimental delayed cerebral vasospasm. J Neurosurg 76:111-118, 1992
31. Nishizawa S, Yamamoto S, Uemura K: Interrelation between protein kinase C and nitric oxide in the development of vasospasm after subarachnoid hemorrhage. Neurol Res 18:89-95, 1996
32. Onoda K, Ono S, Ogihara K, et al: Inhibition of vascular contraction by intracisternal administration of preproendothelin-1 mRNA antisense oligoDNA in a rat experimental vasospasm model. J Neurosurg 85:846-852, 1996
33. Pelech SL, Sanghera JS: MAP kinases: charting the regulatory pathways. Science 257:1355-1356, 1992
34. Peterson JW: Protein kinase C activation during cerebral vasospasm. Stroke 27:342-343, 1996 (Letter)
35. Rodriguez-Viciana P, Warne PH, Vanhaesebroeck B, et al: Activation of phosphoinositide 3-kinase by interaction with Ras and by point mutation. EMBO J 15:2442-2451, 1996
36. Sato M, Tani E, Matsumoto T, et al: Generation of the catalytic fragment of protein kinase C alpha in spastic canine basilar artery. J Neurosurg 87:752-756, 1997
37. Schulze-Osthoff K, Ferrari D, Riehemann K, et al: Regulation of NF-kappa B activation by MAP kinase cascades. Immunobiology 198:35-49, 1997
38. Singer HA, Schworer CM, Sweeley C, et al: Activation of protein kinase C isozymes by contractile stimuli in arterial smooth muscle. Arch Biochem Biophys 299:320-329, 1992
39. Solomon RA, Antunes JL, Chen RYZ, et al: Decrease in cerebral blood flow in rats after experimental subarachnoid hemorrhage: a new animal model. Stroke 16:58-64, 1985
40. Suga J, Yoshimasa Y, Yamada K, et al: Differential activation of mitogen-activated protein kinase by insulin and epidermal growth factor in 3T3-L1 adipocytes. A possible involvement of PI3-kinase in the activation of the MAP kinase by insulin. Diabetes 46:735-741, 1997
41. Sugden PH, Clerk A: Regulation of the ERK subgroup of MAP kinase cascades through G protein-coupled receptors. Cell Signal 9:337-351, 1997
42. cdc2 and mitogen-activated protein kinase homologues. Circ Res 73: 109-117, 1993
43. Winston LA, Hunter T: JAK2, Ras, and Raf are required for activation of extracellular signal-regulated kinase/mitogen-activated protein kinase by growth hormone. J Biol Chem 270: 30837-30840, 1995
44. Zhang H, Weir B, Marton LS, et al: Mechanisms of hemolysate-induced [Ca2+]i elevation in cerebral smooth muscle cells. Am J Physiol 269:H1874-H1890, 1995
45. Zhang J, Lewis AI, Bemanke DH, et al: Stroke: anatomy of a catastrophic event. Anat Rec 253:58-63, 1998
46. Zimmermann M, Seifert V: Endothelin and subarachnoid hemorrhage: an overview. Neurosurgery 43:863-876, 1998
47. Zubkov AY, Lewis AI, Scalzo D, et al: Morphological changes after percutaneous transluminal angioplasty. Surg Neurol 51: 399-403, 1999
48. Zuccarello M, Boccaletti R, Romano A, et al: Endothelin B receptor antagonists attenuate subarachnoid hemorrhage-induced cerebral vasospasm. Stroke 29:1924-1929, 1998